Evidence map›Paper›PMID 26701854›Full record

ArticleOncotarget2016

Microbiota and bile acid profiles in retinoic acid-primed mice that exhibit accelerated liver regeneration.

Hui-Xin Liu, Ying Hu, Yu-Jui Yvonne Wan

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. The Role of Gut Microbiota in Liver Regeneration After Partial Hepatectomy: New Evidence From Animal and Human Studies.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  3. Review
  4. Heliyon · 2024
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. JHEP reports : innovation in hepatology · 2020
    Article
  15. Review
  16. Retinoic acid and microRNA.Methods in enzymology · 2020
    Article
  17. Article
  18. Review
  19. Article
  20. RARβ acts as both an upstream regulator and downstream effector of miR-22, which epigenetically regulates NUR77 to induce apoptosis of colon cancer cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hui-Xin LiuDepartment of Medical Pathology and Laboratory Medicine, University of California, Davis, Sacramento, CA, USA.
Ying HuDepartment of Medical Pathology and Laboratory Medicine, University of California, Davis, Sacramento, CA, USA.
Yu-Jui Yvonne WanDepartment of Medical Pathology and Laboratory Medicine, University of California, Davis, Sacramento, CA, USA.
University of California Davis Medical Center · US

Funding

Retinoids Xenobiotic Metabolism and Tumor PromotionR01CA053596 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI WAN, YU-JUI YVONNE · 1996 to 2014
$4.5M
The Role of Probiotic Bifidobacteria and Bile Acid Metabolism in CarcinogenesisU01CA179582 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MILLS, DAVID ANDREW, SLUPSKY, CAROLYN · 2014 to 2018
$2.8M
Retinoic Acid, Its Receptors, and the LiverR01DK092100 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI WAN, YU-JUI YVONNE · 2011 to 2014
$1.4M
RETINOIC ACID RECEPTOR ALPHA-FETOPROTEIN AND HEPATOMAR29CA053596 · NCI · LA BIOMED RES INST/ HARBOR UCLA MED CTR · PI WAN, YU-JUI YVONNE · 1991 to 1995
–
NCI NIH HHS CA53596NCI NIH HHS R01 CA053596NCI NIH HHS U01 CA179582NCI NIH HHS U01CA179582NIDDK NIH HHS DK092100NIDDK NIH HHS R01 DK092100
6 · The paper itself

Abstract

BACKGROUND &

aimsAll-trans Retinoic acid (RA) regulates hepatic lipid and bile acid homeostasis. Similar to bile acid (BA), RA accelerates partial hepatectomy (PHx)-induced liver regeneration. Because there is a bidirectional regulatory relationship between gut microbiota and BA synthesis, we examined the effect of RA in altering the gut microbial population and BA composition and established their relationship with hepatic biological processes during the active phases of liver regeneration.

methodsC57BL/6 mice were treated with RA orally followed by 2/3 PHx. The roles of RA in shifting gut microbiota and BA profiles as well as hepatocyte metabolism and proliferation were studied.

resultsRA-primed mice exhibited accelerated hepatocyte proliferation revealed by higher numbers of Ki67-positive cells compared to untreated mice. Firmicutes and Bacteroidetes phyla dominated the gut microbial community (>85%) in both control and RA-primed mice after PHx. RA reduced the ratio of Firmicutes to Bacteroidetes, which was associated with a lean phenotype. Consistently, RA-primed mice lacked transient lipid accumulation normally found in regenerating livers. In addition, RA altered BA homeostasis and shifted BA profiles by increasing the ratio of hydrophilic to hydrophobic BAs in regenerating livers. Accordingly, metabolic regulators fibroblast growth factor 21, Sirtuin1, and their downstream targets AMPK and ERK1/2 were more robustly activated in RA-primed than unprimed regenerating livers.

conclusionsPriming mice with RA resulted in a lean microbiota composition and hydrophilic BA profiles, which were associated with facilitated metabolism and enhanced cell proliferation.

Indexed as

MicrobiotaAdministration, OralAMP-Activated Protein KinasesAnimalsBile Acids and SaltsCell ProliferationExtracellular Signal-Regulated MAP KinasesFibroblast Growth FactorsGene ExpressionHepatectomyHepatocytesImmunoblottingKi-67 AntigenLiverLiver RegenerationMaleAMP-Activated Protein KinasesBile Acids and SaltsExtracellular Signal-Regulated MAP Kinasesfibroblast growth factor 21Fibroblast Growth FactorsKi-67 AntigenSirtuin 1Tretinoinenergy metabolismfibroblast growth factor 21gut-liver axislipid homeostasispartial hepatectomyPathology Section

Identifiers

PMID26701854
PMCPMC4811446
OpenAlexW2280598294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.